SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-17-152135
Filing Date
2017-05-01
Accepted
2017-05-01 17:06:07
Documents
3
Effectiveness Date
2017-05-01

Document Format Files

Seq Description Document Type Size
1 DEFA14A d99417ddefa14a.htm DEFA14A 18732
2 GRAPHIC g99417img1.jpg GRAPHIC 255161
3 GRAPHIC g99417img2.jpg GRAPHIC 188297
  Complete submission text file 0001193125-17-152135.txt   630864
Mailing Address 430 EAST 29TH STREET NEW YORK NY 10016
Business Address 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344
Intra-Cellular Therapies, Inc. (Filer) CIK: 0001567514 (see all company filings)

IRS No.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36274 | Film No.: 17801699
SIC: 2834 Pharmaceutical Preparations